PHARMACOKINETICS OF LOW-DOSE ORAL MODIFIED RELEASE, SOLUBLE AND INTRAVENOUS ASPIRIN IN MAN, AND EFFECTS ON PLATELET-FUNCTION

被引：53
作者：
BOCHNER, F
WILLIAMS, DB
MORRIS, PMA
SIEBERT, DM
LLOYD, JV
机构：
[1] FH FAULDING & CO LTD,DIV RES & DEV,ADELAIDE,SA,AUSTRALIA
[2] INST MED & VET SCI,ADELAIDE,SA 5000,AUSTRALIA
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 35卷 / 03期
关键词：
D O I：
10.1007/BF00558267
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：287 / 294
页数：8
相关论文
共 34 条
  • [1] PLASMA ACETYLSALICYLATE AND SALICYLATE AND PLATELET CYCLOOXYGENASE ACTIVITY FOLLOWING PLAIN AND ENTERIC-COATED ASPIRIN
    ALI, M
    MCDONALD, JWD
    THIESSEN, JJ
    COATES, PE
    [J]. STROKE, 1980, 11 (01) : 9 - 13
  • [2] IS THERE AN OPTIMAL DOSE AND FORMULATION OF ASPIRIN TO PREVENT ARTERIAL THROMBOEMBOLISM IN MAN
    BOCHNER, F
    LLOYD, J
    [J]. CLINICAL SCIENCE, 1986, 71 (06) : 625 - 631
  • [3] STATISTICAL ESTIMATIONS IN PHARMACOKINETICS
    BOXENBAU.HG
    RIEGELMA.S
    ELASHOFF, RM
    [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02): : 123 - 148
  • [4] A SENSITIVE LIQUID-CHROMATOGRAPHIC ASSAY FOR PLASMA ASPIRIN AND SALICYLATE CONCENTRATIONS AFTER LOW-DOSES OF ASPIRIN
    BRANDON, RA
    EADIE, MJ
    SMITH, MT
    [J]. THERAPEUTIC DRUG MONITORING, 1985, 7 (02) : 216 - 221
  • [5] SENSITIVITY OF FATTY-ACID CYCLOOXYGENASE FROM HUMAN AORTA TO ACETYLATION BY ASPIRIN
    BURCH, JW
    BAENZIGER, NL
    STANFORD, N
    MAJERUS, PW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (10) : 5181 - 5184
  • [6] CHAM BE, 1980, THER DRUG MONIT, V2, P365
  • [7] DANIEL WW, 1983, BIOSTATISTICS F ANAL
  • [8] EMMETT JAG, 1987, CLIN EXP PHARM PHY S, V10, P78
  • [9] CONTROLLED TRIAL OF ASPIRIN IN CEREBRAL ISCHEMIA
    FIELDS, WS
    LEMAK, NA
    FRANKOWSKI, RF
    HARDY, RJ
    [J]. STROKE, 1977, 8 (03) : 301 - 316
  • [10] FITZPATRICK FA, 1982, METHOD ENZYMOL, P286
1234